Our study demonstrates pervasive activation of ROS-related transcriptional programs in IS and identifies a novel seven-gene signature predictive of disease risk. Among these, CLEC4E emerges as a key mediator connecting ROS dysregulation to immune infiltration and inflammatory signaling, providing new insights into IS pathophysiology and potential therapeutic targets.
Yang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: